8 results
PRE 14C
BTAX
Biostax Corp.
16 Dec 22
Preliminary information
4:31pm
to his tenure at iAnthus, Mr. Farmer was Director of Finance, Integrated Specialty Pharmacy Division of Premier, Inc. (Nasdaq: PINC) from September
8-K
EX-10.1
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
with or separation from the Company.
R-5. For purposes of clarity, this Separation Agreement does not end Phelps’s tenure as a member of the Company’s Board
8-K
BTAX
Biostax Corp.
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
. Prior, he served as Chief Operating Officer at the La Jolla Institute for Immunology; during his tenure the Institute grew from $14M in annual R&D
8-K
EX-99.1
rh94nezeof nlw
3 Jun 22
Departure of Directors or Certain Officers
4:57pm
8-K
cnazag2og19nxqtim213
26 Jan 21
Departure of Directors or Certain Officers
4:35pm
8-K
EX-10.1
nnrlr97slpz u9wir
25 Sep 19
Entry into a Material Definitive Agreement
5:05pm
- Prev
- 1
- Next